Gastro-oesophageal reflux disease in chronic laryngitis: Prevalence and response to acid-suppressive therapy

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 3, 2007, Pages 287-295

  Qua, C S ^a   Wong, C H ^a   Gopala, K ^a   Goh, K L ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; LARYNGOSCOPY; MALE; PH; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; COHORT STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNGITIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMPS;

EID: 33846325809     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03185.x     Document Type: Article

References (36)

1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1-78.
2. Kambic V, Radsel Z. Acid posterior laryngitis: aetiology, histology, diagnosis and treatment. J Laryngol Otol 1984; 98: 1237-40.
3. Katz PO. Ambulatory esophageal and hypopharyngeal pH monitoring in patients with hoarseness. Am J Gastroenterol 1990; 85: 38-40.
4. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002; 16: 564-79.
5. Delahunty JE, Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope 1968; 78: 1941-7.
6. Wiener GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989; 84: 1503-8.
7. Sen P, Georgalas C, Bhattacharyya AK. A systematic review of the role of proton pump inhibitors for symptoms of laryngopharyngeal reflux. Clin Otolaryngol 2006; 31: 20-4.
8. Karkos PD, Wilson JA. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope 2006; 116: 144-8.
9. Williams RBH, Szczesniak MM, Maclean JC, et al. Predictors of outcome in an open label, therapeutic trial of high dose omeprazole in laryngitis. Am J Gastroenterol 2004; 85: 778-88.
10. Wo JM, Grist WJ, Gussack G, et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. Am J Gastroenterol 1997; 92: 2160-5.
11. Kiljander TO, Saloma EM, Hietanen EK, et al. Gastroesophageal reflux in asthmatics. Chest 1999; 116: 1257-64.
12. Amstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1998; 111: 85-92.
13. Hu WH, Wong NY, Lai KC, et al. Normal 24-hour ambulatory proximal and distal gastroesophageal reflux parameters in Chinese. Hong Kong Med J 2002; 8: 168-71.
14. Deschner WK, Benjamin SB. Extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 1989; 84: 1-5.
15. Napierkowski J, Wong RK. Extraesophageal manifestations of GERD. Am J Med Sci 2003; 326: 285-99.
16. Wong CH, Chua CJ, Liam CK, Goh KL. Gastroesophageal reflux disease (GERD) in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy. Aliment Pharmacol Ther 2006; 23: 1321-7.
17. Axford SE, Sharp N, Ross PE, et al. Cell biology of laryngeal epithelial defenses in health and disease: preliminary studies. Ann Otol Rhinol Laryngol 2001; 110: 1099-108.
18. Sontag SJ, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990; 99: 613-20.
19. Harding SM, Susan M, Richter JE, Joel E. The role of gastroesophageal reflux in chronic cough and asthma. Chest 1997; 111: 1389-402.
20. Ylitalo R, Lindestad P, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 2001; 111: 1735-41.
21. Koufman JA, Belafsky PC, Bach KK, et al. Prevalence of esophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope 2002; 112: 1606-9.
22. Garrigues V, Gisbert L, Bastida G, et al. Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. Dig Dis Sci 2003; 48: 2117-23.
23. Klopocka M, Sinkiewicz A, Budzynski J, et al. Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole. Med Sci Monit 2004; 10: 115-8.
24. Habermann W, Kiesler K, Eherer A, et al. Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. J Voice 2002; 16: 425-32.
25. DelGaudio JM, Waring JP. Empiric esomeprazole in the treatment of laryngopharyngeal reflux. Laryngoscope 2003; 113: 598-601.
26. Jasperson D, Weber R, Hammar CH, et al. Effect of omeprazole on the course of reflux associated esophagitis and laryngitis. J Gastroenterol 1996; 31: 765-7.
27. Shaw GY, Searl JP, Young JL, et al. Subjective, laryngoscopic, and acoustic measurements of laryngeal reflux before and after treatment with omeprazole. J Voice 1996; 10: 410-8.
28. Metz DC, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997; 116: 41-6.
29. Fossati D, Passaretti S, Strada E, et al. ENT disorders caused by GERD: efficacy of treatment with pantoprazole. Gastroenterology 2000; 18: 5650-1.
30. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979-83.
31. Steward DL, Wilson KM, Kelly DH, et al. Proton pump inhibitor therapy for chronic laryngopharyngitis: a randomized placebo controlled trial. Otolaryngol Head Neck Surg 2004; 131: 342-50.
32. Vaezi MF, Richter JE, Stasney S, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006; 116: 254-60.
33. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001; 111: 2147-51.
34. Eherer AJ, Habermann HF, Klesler K, et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003; 38: 462-7.
35. Pandolfino JE. Bravo capsule pH monitoring. Am J Gastroenterol 2005; 100: 8-10.
36. Hirano I. Modern technology in the diagnosis of gastro-oesophageal reflux disease - Bilitec, intraluminal impedance and Bravo capsule pH monitoring. Aliment Pharmacol Ther 2006; 23 (Suppl. 1): 12-24.